MedPath

The effect of Enzalutamide and Radium-233 chloride for castration-resistant prostate cancer patients with bone metastasis

Not Applicable
Conditions
castration-resistant prostate cancer patients with bone metastasis
Registration Number
JPRN-UMIN000031347
Lead Sponsor
Fujita Health University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Male
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

The case of Distant metastasis other than bone metastasis or visceral metastasis

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath